1667 related articles for article (PubMed ID: 8666223)
1. [Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome].
Kharkevich GIu; Kazubskaia TP; Agapova RK; Musatov VK; Trubnikov VI; Demidov LV; Gar'kavtseva RF
Genetika; 1995 Nov; 31(11):1562-5. PubMed ID: 8666223
[TBL] [Abstract][Full Text] [Related]
2. Melanocytic naevi, melanoma and sun exposure.
Augustsson A
Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary melanoma revisited.
Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic nevi in association with multiple primary melanoma.
Titus-Ernstoff L; Duray PH; Ernstoff MS; Barnhill RL; Horn PL; Kirkwood JM
Cancer Res; 1988 Feb; 48(4):1016-8. PubMed ID: 3338073
[TBL] [Abstract][Full Text] [Related]
6. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.
Bale SJ; Dracopoli NC; Tucker MA; Clark WH; Fraser MC; Stanger BZ; Green P; Donis-Keller H; Housman DE; Greene MH
N Engl J Med; 1989 May; 320(21):1367-72. PubMed ID: 2716782
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-genetic aspects of cutaneous melanoma. I. Incidence, familial study, genetic heterogeneity].
Gar'kavtseva RF; Sitnikova TS; Kazubskaia TP; Demidov LV; Kharkevich GIu
Genetika; 1995 Nov; 31(11):1557-61. PubMed ID: 8666222
[TBL] [Abstract][Full Text] [Related]
8. [Dysplastic nevus syndrome].
Niebauer G; Kokoschka EM
Wien Klin Wochenschr; 1986 Oct; 98(20):673-8. PubMed ID: 3788185
[TBL] [Abstract][Full Text] [Related]
9. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Engelstein M; Fraser MC; Clark WH; Tucker MA
Am J Hum Genet; 1994 Mar; 54(3):489-96. PubMed ID: 8116618
[TBL] [Abstract][Full Text] [Related]
10. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
[TBL] [Abstract][Full Text] [Related]
11. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
[TBL] [Abstract][Full Text] [Related]
12. [From dysplastic nevus to malignant melanoma--a study of 4 anatomoclinical cases of dysplastic nevus syndrome].
Huynh Do P; Joris F
Praxis (Bern 1994); 1997 Nov; 86(47):1854-9. PubMed ID: 9480503
[TBL] [Abstract][Full Text] [Related]
13. Dysplastic nevi and other risk markers for melanoma.
Seykora J; Elder D
Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Ho EC; Fraser MC; Kearns KS; Bale SJ; McBride OW; Clark WH; Tucker MA
Am J Hum Genet; 1993 Mar; 52(3):537-50. PubMed ID: 8447320
[TBL] [Abstract][Full Text] [Related]
15. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.
Kanetsky PA; Holmes R; Walker A; Najarian D; Swoyer J; Guerry D; Halpern A; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):509-13. PubMed ID: 11352862
[TBL] [Abstract][Full Text] [Related]
16. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Goldstein AM; Martinez M; Tucker MA; Demenais F
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
[TBL] [Abstract][Full Text] [Related]
17. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
[TBL] [Abstract][Full Text] [Related]
19. Dysplastic nevus syndrome among Japanese. A case study and review of the Japanese literature.
Hara K; Nitta Y; Ikeya T
Am J Dermatopathol; 1992 Feb; 14(1):24-31. PubMed ID: 1510212
[TBL] [Abstract][Full Text] [Related]
20. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene.
Puig S; Ruiz A; Castel T; Volpini V; Malvehy J; Cardellach F; Lynch M; Mascaro JM; Estivill X
Hum Genet; 1997 Dec; 101(3):359-64. PubMed ID: 9439668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
